Identification of the subcellular localization of daunorubicin in multidrug-resistant K562 cell line

被引:33
|
作者
Gong, YP [1 ]
Wang, YT [1 ]
Chen, FY [1 ]
Han, JY [1 ]
Miao, JM [1 ]
Shao, NX [1 ]
Fang, ZW [1 ]
Yang, RO [1 ]
机构
[1] Shanghai Second Med Univ, Leukemia Unit, Renji Hosp, Shanghai Inst Hematol, Shanghai 200001, Peoples R China
关键词
resistant k562 cell line; subcellular distribution; confocal laser scanning microscopy; P-glycoprotein;
D O I
10.1016/S0145-2126(00)00048-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We examined the subcellular distribution of daunorubicin (DNR) in resistant K562 cell line which overexpress the P-glycoprotein by confocal laser scanning microscopy. Three fluorescent probes - Rhodamine123, neutral red, NBD-ceramide, which stain the mitochondria, lysosomes, Golgi apparatus respectively, were used to identify the nature of the subcellular compartment sequestering daunorubicin. In sensitive k562 cell line, nuclear and cytoplasmic DNR fluorescence was intense and diffuse. In contrast, resistant K562 cell line showed a different DNR distribution. A bright fluorescence signal was located in the perinuclear region and peripheral plasma, the nucleus and other cytoplasmic region appear as empty, as suggested by the distribution of fluorescent probe Rhodamine123 specifically for mitochondria. Verapamil, an effective resistance modulator in P-glycoprotein MDR cells, restored the DNR distribution closer to that in the parent cells. Golgic inhibitor brefeldin A and lysosomotropic agent chloroquine had little effect on drug sequestration. Our studies demonstrate that daunorubicin may be sequestered in mitochondrial compartment in the resistant cells and P-glycoprotein plays an important role on mediating DNR transport. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:769 / 774
页数:6
相关论文
共 50 条
  • [41] Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms
    Hekmatshoar, Yalda
    Ozkan, Tulin
    Gunes, Buket Altinok
    Bozkurt, Sureyya
    Karadag, Aynur
    Karabay, Arzu Zeynep
    Sunguroglu, Asuman
    CELLULAR AND MOLECULAR BIOLOGY, 2018, 64 (06) : 23 - 30
  • [42] DNA-MEDIATED TRANSFER AND CLONING OF A HUMAN MULTIDRUG-RESISTANT GENE OF ADRIAMYCIN-RESISTANT MYELOGENOUS LEUKEMIA K562 CELLS
    SUGIMOTO, Y
    TSURUO, T
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 284 - 284
  • [43] Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line
    Bai, Haitao
    Xu, Rang
    Cao, Zhongwei
    Wei, Daolin
    Wang, Chun
    FEBS LETTERS, 2011, 585 (02) : 402 - 408
  • [44] K562 - HUMAN ERYTHROLEUKEMIC CELL-LINE
    ANDERSSON, LC
    NILSSON, K
    GAHMBERG, CG
    INTERNATIONAL JOURNAL OF CANCER, 1979, 23 (02) : 143 - 147
  • [45] ATP/MG2+-DEPENDENT BINDING OF VINCRISTINE TO THE PLASMA-MEMBRANE OF MULTIDRUG-RESISTANT K562 CELLS
    NAITO, M
    HAMADA, H
    TSURUO, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (24) : 11887 - 11891
  • [46] EXPRESSION OF P-GLYCOPROTEIN IN MULTIDRUG-RESISTANT HUMAN LEUKEMIA K562 CELLS DURING ERYTHROID-DIFFERENTIATION
    FARDEL, O
    ESCANDE, F
    RAULT, B
    DRENOU, B
    LEBESCOT, J
    FAUCHET, R
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (02) : 377 - 381
  • [47] Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells
    Cui, Xue Yan
    Skretting, Grethe
    Jing, Ying
    Sun, Hui
    Sandset, Per Morten
    Sun, Ling
    BLOOD CELLS MOLECULES AND DISEASES, 2013, 51 (03) : 177 - 184
  • [48] Modulator activity of pyronaridine in multidrug resistant human leukemic cell line K562/A02and its xenografts in nude mice
    Qi, J
    Wang, SB
    Liu, GY
    Peng, H
    Wang, JX
    Yang, CZ
    BLOOD, 2002, 100 (11) : 213B - 213B
  • [49] Identification of a novel partner gene of CAN,from the K562 cell line.
    Takami, Y
    Nakazato, H
    Oikawa, T
    Tojo, A
    Asano, S
    Sato, Y
    BLOOD, 1999, 94 (10) : 186B - 186B
  • [50] Dexrazoxane prevents the emergence of multidrug resistance in the human leukaemia line, K562
    Sargent, J
    Williamson, C
    Taylor, C
    Hellmann, K
    BRITISH JOURNAL OF CANCER, 2000, 83 : 17 - 17